bearish
Another Negative Sign for Celltrion: Remsima Retail Price Is Falling Too Fast Too Much
747 Views30 Aug 2018 10:29
Celltrion Healthcare (091990 KS) submitted its 1H18 semi-annual report yesterday. And with this semi-annual report, we finally got to know the...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
- Close Long/Short on Celltrion/Celltrion Healthcare: Market Mood on Placement Is Surprisingly Mild20 Sep 2018
- Celltrion Healthcare Placement: Two Mitigating Factors, Short Healthcare But Long Celltrion18 Sep 2018
- Celltrion Healthcare Placement: Weigh Down from FDA Uncertainty and Placement Overhang18 Sep 2018
- Another Negative Sign for Celltrion: Remsima Retail Price Is Falling Too Fast Too Much30 Aug 2018
- Celltrion (068270): Time Is Not Right for Short Sellers Yet14 Aug 2018
- A Further Study on Celltrion-Celltrion Healthcare Market Cap Spread Movement28 May 2018
- Celltrion's FDA CRL Issue Summary09 Apr 2018
x